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Abstract In this article, we present a multispecies reaction-advection-diffusion
partial differential equation (PDE) coupled with linear elasticity for model-
ing tumor growth. The model aims to capture the phenomenological features
of glioblastoma multiforme observed in magnetic resonance imaging (MRI)
scans. These include enhancing and necrotic tumor structures, brain edema
and the so called “mass effect”, that is, the deformation of brain tissue due to
the presence of the tumor. The multispecies model accounts for proliferating,
invasive and necrotic tumor cells as well as a simple model for nutrition con-
sumption and tumor-induced brain edema. The coupling of the model with
linear elasticity equations with variable coefficients allows us to capture the
mechanical deformations due to the tumor growth on surrounding tissues. We
present the overall formulation along with a novel operator-splitting scheme
with components that include linearly-implicit preconditioned elliptic solvers,
and semi-Lagrangian method for advection. Also, we present results showing
simulated MRI images which highlight the capability of our method to capture
the overall structure of glioblastomas in MRIs.
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1 Introduction
Glioblastomas form a class of highly aggressive tumors, accounting for a ma-
jority of all malignant primary brain tumors in adults (Dolecek et al., 2012),
with a median survival rate of less than a year (Newton, 1994; Salcman, 1980;
Seither et al., 1995; Swanson et al., 2008; Wrensch et al., 2002).
Mathematical modeling of glioblastoma tumor growth has been extensively
used to assist in image analysis of MRIs (Gooya et al., 2011), as well as
the diagnosis, treatment, and prognosis of glioblastomas (Akbari et al., 2016;
Hawkins-Daarud et al., 2013a; Macyszyn et al., 2016; Szeto et al., 2009). Be-
yond glioblastomas, there is a large body of work for generic tumor growth
modeling at different scales and different scenarios (e.g., in vitro, animal mod-
els, multiscale models) that attempt to capture the complex biological prin-
ciples underlying tumor dynamics, by accounting for phenomena on cellu-
lar scales or continuum/tissue scales. In this paper, we are primarily inter-
ested in capturing the phenomenological features of malignant glioblastomas
or glioblastomas, observed from MRI scans. These include
– enhancing rim of proliferating tumor cells,
– central tumor core filled with necrotic/dead cells,
– brain edema, and
– mass effect.
Our end goal is to couple this model with parameter estimation methods and
with patient MRIs in order to assist in diagnosis and prognosis. The model
also finds applications in areas like MR image segmentation of glioblastomas.
For example, our model is incorporated in the training of neural networks on
synthetic datasets as a data augmentation strategy in Gholami et al. (2018).
Here we only present the overall formulation.
A single species reaction-diffusion PDE has been one of the most popular mod-
eling frameworks (Clatz et al., 2005; Hogea et al., 2007a, 2008a; Jbabdi et al.,
2005; Konukoglu et al., 2010b; Mang et al., 2012; Rekik et al., 2013; Swan-
son et al., 2000, 2002). This simple model attempts to capture two distinct
behaviors of malignant tumor growth: proliferation (reaction) and infiltration
(diffusion). However it captures neither the mass effect nor the distinct imaging
characteristics of the visible tumor in MRI. One of the most distinct features
of glioblastomas is the presence of a proliferative rim of tumor cells surround-
ing a central necrotic core (dead tumor cells). The proliferative rim contains
enhancing and non-enhancing tumor cells visible from different MRI contrasts.
Moreover, imaging also highlights regions of peritumoral edema. Edema typi-
cally surrounds the proliferative rim and is known to be dispersed with highly
migratory tumor cells, called infiltrative or invasive tumor cells. These cells,
themselves, are not visible in MRI scans. They invade healthy parenchyma
to distances that measure several centimeters beyond the detectable tumor
core (Giese et al., 2003). These cells are also able to invade even in the presence
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(a) (b) (c) (d) (e)
Fig. 1: Illustration of the phenomenological structures of a glioblastoma from MRI scans.
All images are 2D slices of 3D volumetric datasets (Top row) These images correspond to
a specific axial slice of (a) FLAIR, (b) T1, (c) T1-Gd, (d) T2 MRI and (e) segmentation
of a real patient brain, taken from the Multimodal Brain Tumor Segmentation Challenge,
2017 (Bakas et al., 2017; Menze et al., 2015) training dataset. The peritumoral edema
(light gray segmentation) is visible in the hyper-intense signal in the FLAIR image, while
the enhancing tumor structures (white segmentation) and necrotic tumor core (dark gray
segmentation) are visible in the T1-Gd MRI scan. We can also observe a noticeable amount
of mass effect. (Bottom row) Simulated MRI modalities from our current multispecies model
with mass effect. These are generated by growing a synthetic tumor in silico using a healthy
brain image. Once we solve our model, we create images by using correlations between tissue
type and MRI intensity obtained by existing segmentations. We use the scans (and their
corresponding segmentations) from the GLISTR dataset (Gooya et al., 2012) to achieve this.
As one can see, the simulation captures many of the important features present in a real
MR image.
.
of treatment and can escape surgical resections, leading to recurrence (Giese
et al., 2003). Thus, the extent of tumor invasion along with the sub-structures
of a glioblastoma are highly important factors when planning treatment op-
tions and estimating survival times for the patient. An illustration of these
imaging characteristics is shown in Fig. 1.
Our hypothesis is that by designing a model that can capture these imaging
characteristics (edema, enhancing and necrotic tumor, and mass effect), we
will be able to extract clinically useful information. The model parameters
can be inferred in a patient-specific manner and help improve the mathemati-
cal characterization of tumor, which ultimately betters the clinical outcome. In
this paper, our goal is modest. We introduce a possible model that integrates
the structure of a glioblastoma with its mechanical effects on surrounding
brain tissue. Multispecies models are useful in this context as they help in
delineating the different tumor regions effectively without ad-hoc threshold-
ing operations, which one might have to use when working with single species
models. However, we also want to emphasize that we tried to design a model
that it is as simple as possible so it can be used in a robust way for param-
eter estimation. Indeed, highly complex, first principle models include many
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more tumor species, angiogenesis, chemotaxis, porous media that capture the
interstitial fluid and extracellular matrix, and sophisticated models of growth.
However, such models have a very large number of unknown parameters and
pose outstanding numerical challenges with respect to both simulation and
parameter estimation. Following the ideas in (Yankeelov et al., 2013), our goal
here is to introduce a minimal model that serves our clinical objective.
Related work: There have been varied approaches to modeling this phenomena
on a molecular basis to a tissue (continuum) level (Bellomo et al., 2008; Oden
et al., 2013).
The most widely used tumor-growth model is the single species, reaction-
diffusion model (Murray, 1989). This model has proven to be quite effective
in describing the whole tumor structure of glioblastomas (Clatz et al., 2005;
Hogea et al., 2007a; Jbabdi et al., 2005; Konukoglu et al., 2010b; Mang et al.,
2012; Rekik et al., 2013; Swanson et al., 2000, 2002). But tumors are very com-
plex. The underlying processes include mitosis, invasion, angiogenesis, biome-
chanics, environment quality, genotype, and gene expression. Approaches span
from modeling each tumor phenotype on a cellular level (Alarco´n et al., 2003;
Anderson et al., 2009; Gerlee and Anderson, 2009) to macroscopic descriptions
of tumor densities and nutrient supply (Bellomo et al., 2008; Hawkins-Daarud
et al., 2013b; Konukoglu et al., 2010a,b; Oden et al., 2013; Swanson, 2008;
Swanson et al., 2011)). One of the simplest multispecies models is based on
the go-or-grow hypothesis for differentiation. This hypothesis stems from ex-
perimental evidence (Giese et al., 2003, 1996) that suggests the existence of
tumor cells in two states: one which proliferates quickly, but moves slowly
(the proliferative one) and another which rapidly migrates but proliferates
slowly (the invasive one). Further, tumor cells can mutate into the other phe-
notype based on the tumor microenvironment: cells become more migrating in
a dearth of nutrients and proliferating in rich environments (Hatzikirou et al.,
2012). While some models conform to the “go-or-grow” hypothesis (Pham
et al., 2012; Saut et al., 2014), others do not consider this phenotype. Swan-
son et al. (2011) stipulate the existence of normoxic and hypoxic tumor cells
which migrate at the same rate. These are complex multispecies models but
they do not include mass effect, which is important for both low and high-
grade glioblastomas. MRI scans of patient brains with different ranges of mass
effect are shown in Fig. 2.
Although tumor models date to the 1950s, models with mass effect are more
recent. Early models (Hogea et al., 2006; Mohamed and Davatzikos, 2005) de-
coupled mass effect from tumor growth. The brain was modeled as an elastic
material with external forces controlling the size of the tumor and displace-
ments of surrounding tissue. More recent models, specifically the ones intro-
duced in Hogea et al. (2007a); Hormuth et al. (2018); Rahman et al. (2017),
couple tumor dynamics with elasticity equations. These models show flexibil-
ity in capturing complex/realistic tumor shapes and associated mass effect.
These models, however, only deal with a single species of tumor cells.
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Fig. 2: T1 MRI scans of (a) a healthy brain, (b) brain with negligible mass effect, (c)
moderate mass effect and (d) significant mass effect.
Contributions: In this paper, we propose a new model for tumor growth dy-
namics of glioblastomas, a novel numerical scheme, and we present exemplary
results. In particular:
1. We propose a new go-or-grow, multispecies model coupled with an elastic-
ity model for mass effect (§2). We model proliferative cells, invasive cells,
necrotic cells and oxygen concentration. We use a new, mass-conserving for-
mulation that excludes the cerebrospinal fluid (which is not mass-conserved
in the MR-defined control volume we use). In addition, we introduce a
screened elasticity model that can better localize mass effect.
2. We propose and test novel numerical schemes to discretize and solve the
resulting model PDEs (§3). Introducing a two-way coupling between the
tumor evolution equations and linear elasticity results in challenging nu-
merical problems as it leads to time dependence of various material and
tumor properties. This is because the brain geometry changes as the tumor
grows (due to the mass effect). Further, solving the linear elasticity equa-
tions is computationally challenging. The elasticity operator contains time
and space varying coefficients, and the non-linearity of the tumor growth
model adds to the numerical challenges. The numerical schemes used in our
solver include stable pseudo-spectral methods, a semi-Lagrangian scheme
for transport equations and preconditioners for the variable elasticity and
diffusion equations.
3. In the results section §4, we compare our model with a single species model
with and without mass effect. We perform sensitivity analysis of our model
parameters and finally present synthetic MR images highlighting the char-
acteristic features of a glioblastoma.
Our model is inspired by Hogea et al. (2007b) for the elasticity model and Saut
et al. (2014) for the multispecies model. We detail the differences of our model
with these two models in Section 2.
Limitations: Phenomenological models can account for a wide range of com-
plex phenomena. An important phenomenon is angiogenesis, which can be
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measured with perfusion MRI data. We do not include angiogenesis as we
wanted to minimize the number of unknown parameters to the extent pos-
sible. However, even without angiogenesis our model has many parameters,
many of which are patient specific. This is related to the second limitation,
which is lack of validation. One way to validate our model is to infer model pa-
rameters from actual patients and examine the mismatch between our model
predictions and real patient data (see Gholami et al. (2016) for inverse tu-
mor problem formulations with single species reaction-diffusion models). The
model we present here is much more complicated, and the latter approach is
the focus of our immediate future work.
2 Forward Tumor Mathematical Model
In the following subsections, we first introduce the screened elasticity model
for mass effect, second we introduce the mass-conserving single species model
with elasticity coupling and finally, the overall multispecies model. We also use
the single species model for comparisons with our multispecies model.
2.1 Elasticity model
We model the displacement (u) due to tumor-induced mass effect using linear
elasticity. The governing equations of linear elasticity for an isotropic medium
are given by
T = λtr(E)I + 2µE, (1a)
∇ · (µ(∇u +∇uT )) +∇(λ∇ · u) + b = 0 in Ω, (1b)
where T is the stress tensor, E is the infinitesimal strain tensor, (λ, µ) are
Lame´ coefficients and b is the total body force. In order to prevent excessive
shear to limit far field effects of the resulting force, our model supports the
screening of the elasticity equation with a screening coefficient, η(x, t), which
will be a function of tumor concentration. We take η to be zero in the presence
of tumor cells, and a high value elsewhere to screen the effects of the tumor.
We show examples of the effects of screening in §4. We write the screened
elasticity equation in a more compact form as:
− ηu + Lu = b in Ω , (2)
where by L we denote the linear elasticity operator. The screening coefficient
η can be varied to obtain different mass effect ranges and subsequent defor-
mations of the material properties. The Lame´ coefficients (λ(x, t), µ(x, t)) are
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computed as:
µ =
∑
s
Es
2(1 + νs)
ιs (3a)
λ =
∑
s
νsEs
(1− 2νs)(1 + νs) ιs. (3b)
Here, ιs(x, t) is the concentration of the constituent species s (tumor and
healthy cells), Es is the Young’s modulus of the species s and νs is Poisson’s
ratio of the species s.
2.2 Reaction-diffusion model coupled with linear elasticity
The single species tumor model consists of a conservation equation with re-
action and diffusion source terms for the evolution of the tumor cell concen-
tration, c(x, t), and is coupled with the linear elasticity equation (Eq. 2). The
model can be summarized by the following equations:
∂tc+∇ · (cut)−Dc−R = 0 in Ω × (0, 1] (4a)
c0 − Φp = 0 in Ω (4b)
−ηu + Lu− b = 0 in Ω × (0, 1] (4c)
∂tg +∇ · (gut) + g
g + w
(Dc+R) = 0 in Ω × (0, 1] (4d)
∂tw +∇ · (wut) + w
g + w
(Dc+R) = 0 in Ω × (0, 1] (4e)
∂tf +∇f · ut = 0 in Ω × (0, 1] (4f)
g − g0 = 0 in Ω (4g)
w − w0 = 0 in Ω (4h)
f − f0 = 0 in Ω. (4i)
The basic model notation is described in Table 1. We briefly explain the indi-
vidual components of the model below.
Our goal is to be able to decide the properties of a voxel in order to create
a segmentation that we can compare with MRI imaging data. Therefore, we
introduce the following assumption: the total cell density is mass-conserved
(similar to the assumptions introduced in Saut et al. (2014)). We define the
total cell density as a sum of all component densities, i.e:
c+ g + w = m, (5)
where m is the total cell density, which we assume is conserved. It thus satis-
fies:
∂tm+∇ · (mut) = 0 in Ω × (0, 1]. (6)
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Table 1: Common notations for the reaction-diffusion tumor model.
Notation Description
c(x, t) Tumor concentration
g(x, t) Gray matter concentration
w(x, t) White matter concentration
f(x, t) Cerebrospinal fluid density
(c0(x), g0(x), w0(x), f0(x)) Initial conditions for corresponding cell densities
ut(x, t) Advection velocity
b(x, t) Linear elasticity forcing function
D (see Eq. 7) Diffusion operator
R (see Eq. 9) Reaction operator
x = (x, y, z) Spatial location
t Time
Ω Spatial domain
Φ
Gaussian basis functions for tumor initial condition
parameterization
p ∈ IRNp Tumor inital condition parameterization
Then the conservation laws for the healthy cells, Eq. 4d and Eq. 4e, follow
from Eq. 6. Notice that the cerebrospinal fluid is not included. We apply a pure
advection equation (Eq. 4f) to the cerebrospinal fluid to account for possible
leakage. This approach differs from the one in Hogea et al. (2007b), where
the evolution of material properties is not in conservative form and does not
account for the loss of healthy cells through tumor growth and invasion.
The differential operator, D, is the inhomogeneous isotropic diffusion opera-
tor:
Dc = ∇· (K(g(x, t), w(x, t), f(x, t),x)∇c). (7)
The diffusion coefficient, K is given by
K(g(x, t), w(x, t),x) = kgg(x, t)I + kww(x, t)I, (8)
where kg and kw are the constant diffusion rates in gray and white mat-
ter, respectively. The reaction operator is a non-linear logistic growth func-
tion:
R = ρ(x, t)c(1− c), (9)
where
ρ(x, t) = ρgg(x, t) + ρww(x, t). (10)
Here, ρg and ρw are constant growth rates in gray and white matter, re-
spectively. Note that the diffusion and reaction operators now depend on the
material properties that change in time. This is due to the evolution of the
tumor growth, which in turn displaces the surrounding tissue.
The forcing function for the linear elasticity equations is modeled as
b = ζtanh(c)∇c, (11)
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where ζ is a constant. The choice of the force function is not unique and
other formulations are possible as well (Hogea et al., 2008b). Here, we assume
that the force exerted on the brain tissue is proportional to tumor concentra-
tion gradient. The addition of the tanh(c) term is to enforce small displace-
ment forces where the tumor concentration is small. More complex models like
poroelasticity or growth models (Goriely and Moulton, 2011), which change
the constitutive equation and write the deformation gradient as a product of
an elastic and growth term can be used, but these are highly nonlinear and
with a large number of unknown parameters. Since here we are not developing
a first-principles model but instead a more phenomenological model to be used
in conjunction with imaging information, we use the simple linear elasticity
model of §2.1.
Regarding boundary conditions, we assume zero tumor flux on the skull and
cerebrospinal fluid boundaries and zero displacement on the skull. The Lame´
coefficients are different depending on the tissue type (tumor, gray matter,
white matter, cerebrospinal fluid). In our model (both single and multi-species),
we assume that the healthy tissues of the brain are slightly compressible and
the tumorous tissues are nearly incompressible with a Young’s modulus sim-
ilar to that of healthy tissues. The cerebrospinal fluid is modeled as a highly
compressible and soft material. The different model parameters used for our
simulations are highlighted in Table 3.
2.3 Multispecies model coupled with linear elasticity
We modify the model introduced by Saut et al. (2014) and couple it with linear
elasticity equations to capture mass effect. The basic structure of Saut et al.
(2014) assumes that active tumor cells to exist in either one of two states,
proliferative and invasive. If the tumor microenvironment has sufficient con-
centration of oxygen and other nutrients, the tumor cells grow through rapid
mitosis by consuming those nutrients. If the oxygen concentration becomes low
(hypoxia), the cells switch from proliferative to invasive. Invasive cells migrate
to surrounding areas with higher nutrition concentration and switch back to
proliferating cells when such an environment becomes available. This model
assumes the only significant environmental factor affecting the state of tumor
cells to be oxygen. In the event of severe hypoxia, the tumor cells die and
become necrotic, typically located in the center of the tumor. The model is
given by the following set of partial differential equations.
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Table 2: Common notations for the multispecies go-or-grow tumor model.
Notation Description
p(x, t) Proliferative tumor cell concentration
i(x, t) Invasive tumor cell concentration
n(x, t) Necrotic tumor cell concentration
o(x, t) Oxygen concentration
oheal Healthy cell oxygen concentration
α(x, t) (see Eq. (17)) transition rate from p to i cells
β(x, t) (see Eq. (18)) transition rate from i to p cells
h(x, t) (see Eq. (14)) Oxygen threshold function
R (see Eq. (15)) Proliferative cell reaction operator
R˜ (see Eq. (16)) Invasive cell reaction operator
δp Oxygen consumption rate
δs Oxygen supply rate
∂tp+∇· (put)−R+ αp− βi+ hp = 0 in Ω × (0, 1] (12a)
p0 − Φp = 0 in Ω (12b)
∂ti+∇· (iut)−Di− R˜+ βi− αp+ hi = 0 in Ω × (0, 1] (12c)
i0 − Φp˜ = 0 in Ω (12d)
∂tn+∇· (nut)− hp− hi− h(g + w) = 0 in Ω × (0, 1] (12e)
n0 = 0 in Ω (12f)
∂to−Do+ δpp− δs(oheal − o)(g + w) = 0 in Ω × (0, 1] (12g)
o0 − oheal = 0 in Ω (12h)
−ηu + Lu− b = 0 in Ω × (0, 1] (12i)
∂tg +∇ · (gut) + g
g + w
(
D +R+ R˜
)
+ hg = 0 in Ω × (0, 1] (12j)
∂tw +∇ · (wut) + w
g + w
(
D +R+ R˜
)
+ hw = 0 in Ω × (0, 1] (12k)
∂tf +∇f · ut = 0 in Ω × (0, 1] (12l)
g − g0 = 0 in Ω (12m)
w − w0 = 0 in Ω (12n)
f − f0 = 0 in Ω. (12o)
The common notations used in the multispecies model are outlined in Table
2. We provide a brief description of the details of the model below.
The governing equation for proliferative cells is a conservation equation with
the following source terms: reaction corresponding to cell mitosis in favorable
environments, phenotype switches between proliferative and invasive based
on the quality of the environment and a death term in hypoxic regions. The
evolution of invasive cells is governed by a diffusion equation with source terms
representing similar behavior as proliferative cells. The conservation equation
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for necrotic cells is primarily driven by sources corresponding to the death of
tumorous and healthy cells in hypoxic environments.
Ignoring cerebrospinal fluid, we define the total cell density as:
p+ i+ n+ g + w = m. (13)
The conservation laws for the healthy cells follow from the mass conservation
of the total cell density (similar to the single species model). We use a pure
advection equation to model the evolution of the cerebrospinal fluid.
We use a thresholding function h based on the concentration of oxygen to
model the death of cancer and healthy cells through a death rate γ:
h = γH(ohypoxia − o), (14)
where ohypoxia is the hypoxia threshold and H is a smoothed Heaviside func-
tion. We model the reaction operator for the proliferative cells R as:
R =

ρp(1− p), o > oinv(
o− omit
oinv − omit
)
ρp(1− p), oinv ≥ o ≥ omit
0, o < omit,
(15)
where omit and oinv are mitosis and invasive oxygen thresholds, respectively.
We use omit = (ohypoxia + oinv)/2. Here, ρ = ρ(x, t) is the proliferation rate as
defined in Eq. 9. For invasive cells, the reaction operator R˜ is similarly defined
as
R˜ =

ρi(1− i), o > oinv(
o− omit
oinv − omit
)
ρi(1− i), oinv ≥ o ≥ omit
0, o < omit.
(16)
We assume that invasive cells proliferate at a much smaller rate compared to
proliferative cells. We take ρiw, the proliferation rate of invasive cells in white
matter as a small fraction of ρw (see Eq. 9). We model the transition rate α
as a decreasing function of oxygen concentration by the expression:
α = α0H(oinv − o). (17)
The transition rate β is modeled as:
β = β0(H(σb − p− i)o), (18)
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where σb is a threshold above which the transition to p is prohibited. The
rate is an increasing function of oxygen concentration to prevent cells from
converting to the proliferative phenotype in scarcity of oxygen.
The evolution of oxygen is modeled through a diffusion equation. The source
of oxygen is assumed to be proportional to the concentration of healthy cells
and oxygen is consumed by proliferation at a constant rate δp.
We use
b = ζtanh(p+ n)∇(p+ n). (19)
for the forcing function of the linear elasticity, similar to the single-species
model.
2.4 Tumor-associated brain edema model
Cerebral edema in glioblastomas arise primarily from the leakage of protein
and fluid into the extra-cellular matrix of the brain. Edema is a prominent
image phenotype of glioblastomas, since it is clearly visible in MR images
and is typically infiltrated by invasive tumor cells that lead to post-resection
recurrence. The mechanism of fluid accumulation due to the tumor is often
modeled as a consequence of the infiltrative property of tumor cells. We choose
a model based on the works of Hawkins-Daarud et al. (2013b). The infiltrative
tumor cells cause the fluid to leak into the extra-cellular space, where it moves
through diffusion. A constant drainage term models the re-absorption of fluid
into the vascular system. The equations governing the evolution of edema
are one-way coupled to the multispecies tumor growth model and are given
below.
lt = Dl + δe i
i+ δhalf
(1− i)− δll, (20)
where l is the edematous fluid concentration, δe is a measure of the trans-
mission rate of edema into the extra-cellular space, δhalf is the concentration
of invasive cells at which δe reaches half of its maximum value and δl is the
rate of drainage of edema back into the system. We note that the nature of
edematous fluid from MRI images can also be approximated by:
l = (1− p− i− n)H(i− ithreshold). (21)
with some threshold value chosen for invasive cells, ithreshold.
2.5 Model parameters
The multi-species model presented above has 27 parameters (essentially ma-
terial properties). Approximate (range of) values are give for some of these
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parameteres in the literature, and we use those values from the literature. The
values for the various model parameters are summarized in Table 3. In par-
ticular, we refer to Gholami et al. (2016) for reaction and diffusion coefficient
values, Saut et al. (2014) for the multispecies model parameter values, Hogea
et al. (2007b) for the elasticity model parameter values and Hawkins-Daarud
et al. (2013b) for the edema model parameter values. For screening coefficient
values and edema model parameter values, we experiment with different values
to produce reasonable qualitative characteristics of mass effect and edema in
MRI images.
3 Discretization and numerical scheme
We use the Strang operator splitting method (Strang, 1968) in conjunction
with pseudospectral methods to numerically solve the non-linear system of
PDEs. First, we describe the discretization scheme for the single species model
outlined in Eq. 4. Then, we describe the discretization for the multispecies
model.
We use a fictitious domain method where the brain is assumed to reside in
a cubic box. The space is discretized uniformly into 2563 nodes with spatial
resolution 1mm× 1mm× 1mm.
Given tumor concentration cn at time step n, healthy tissue concentrations
(gn, wn, fn), and corresponding material-dependent reaction and diffusion co-
efficients, we solve the single species model (Eq. 4) through the following op-
erator splitting steps:
– Solve the advection equations ∂tq+∇· (qut) = 0 for q = (c, g, w) over time
∆t using the semi-Lagrangian method (see Falcone and Ferretti (1998);
Mang et al. (2016)), with (cn, gn, wn) as initial condition and current ve-
locity unt to obtain (c
†, g†, w†).
– Solve the advection equation ∂tf+∇f ·ut = 0 for f over time ∆t using the
semi-Lagrangian method with fn as initial condition and current velocity
unt to obtain f
n+1.
– Solve the diffusion equation ∂tc − Dc = 0 over time ∆t using the Crank-
Nicolson method ( Crank and Nicolson (1996)) with c† as initial condition
to obtain c††.
– Solve the reaction equations ∂tq − Rq = 0 over time ∆t explicitly with
(c††, g†, w†) as initial condition to obtain (cn+1, gn+1, wn+1). Here, Rq is
the reaction/source operator for Eq. 4a, Eq. 4d and Eq. 4e. Update the
reaction, diffusion and elasticity coefficients using the new healthy tissue
and tumor concentration.
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Table 3: Model parameters used in the forward simulations. For the screening parameters,
we experiment with different values to obtain the best results (see §4.1 for other range of
values that can be used and the sensitivity of the model to these values). For the edema
model parameters, we refer to Hawkins-Daarud et al. (2013b) and experiment with different
values to produce the qualitative characteristics of edema in MRI images.
Parameter Value
Reaction and diffusion coefficients (see Gholami et al. (2015))
Diffusion coefficient in white matter, kw (see Eq. (8)) 0.1
Diffusion coefficient in gray matter, kg (see Eq. (8)) 0
Reaction coefficient in white matter, ρw (see Eq. (10)) 8
Reaction coefficient in gray matter, ρg (see Eq. (10)) 0
Reaction coefficient of invasive cells in white matter, ρiw (see Eq.
(16))
0.8
Go-or-grow model parameters (see Saut et al. (2014))
Transition rate coefficient from p to i, α0 (see Eq. (17)) 0.15
Transition rate coefficient from i to p, β0 (see Eq. (18)) 0.02
Death rate, γ (see Eq. (14)) 1
Transition threshold from i to p, σb (see Eq. (18)) 0.9
Hypoxia oxygen threshold, ohypoxia (see Eq. (14)) 0.65
Invasive oxygen threshold, oinv (see Eq. (15)) 0.7
Oxygen supply, δs (see Eq. (12g)) 55
Oxygen consumption rate, δp (see Eq. (12g)) 8
Screening parameters
Screening factor in tumor cells, ηtumor (see Eq. (2)) 0
Screening factor in healthy cells, ηhealthy cells (see Eq. (2)) 10000
Screening factor in background, ηbackground (see Eq. (2)) 10
6
Elasticity material properties (see Hogea et al. (2007a))
Young’s modulus of gray matter, Egm (Pa) (see Eq. (3)) 2100
Young’s modulus of white matter, Ewm (Pa) (see Eq. (3)) 2100
Young’s modulus of cerebrospinal fluid, Ecsf (Pa) (see Eq. (3)) 100
Young’s modulus of tumor, Etumor (Pa) (see Eq. (3)) 2100
Young’s modulus of background material, Ebcg (Pa) (see Eq. (3)) 15000
Poisson’s ratio of gray matter, νgm (see Eq. (3)) 0.3
Poisson’s ratio of white matter, νwm (see Eq. (3)) 0.3
Poisson’s ratio of cerebrospinal fluid, νcsf (see Eq. (3)) 0.1
Poisson’s ratio of background material, νbcg (see Eq. (3)) 0.48
Poisson’s ratio of tumor, νtumor (see Eq. (3)) 0.45
Forcing function constant, ζ (see Eq. (11)) 40000
Edema model parameters
Transmission rate of edematous fluid into extra-cellular space, δe (see
Eq. (20)))
40
Half-max invasive concentration, δhalf (see Eq. (20))) 0.01
Drainage rate of edematous fluid, δl (see Eq. (20))) 80
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– Solve the variable linear elasticity equation (Eq. 4c) using Krylov subspace
methods with forcing function computed from cn+1 and Lame´ coefficients
computed from (gn+1, wn+1, fn+1) to obtain un+1. Update velocity un+1t
using backward time differencing.
Now, we provide specific details of each step. For the diffusion equation, we
use a pseudo-spectral spatial discretization with a Crank-Nicolson scheme in
time. The diffusion equation reduces to:
(
1− ∆t
2
D
)
cn+1 =
(
1 +
∆t
2
D
)
cn. (22)
We solve this symmetric, implicit system of equations using the Conjugate
Gradient (CG) method. We precondition this Krylov solver by solving the
diffusion equation using constant coefficients computed by averaging the inho-
mogeneous diffusion coefficient over the spatial domain (similar to the works
of Gholami et al. (2015)).
All transport equations are solved using a semi-Lagrangian scheme, which
is unconditionally stable for solving the linear advection equations. We use a
second order in time and third order in space (for interpolation) to solve for the
semi-Lagrangian trajectories of a scalar field, ν(x, t). Here, we briefly describe
the semi- Lagrangian scheme using the following transport equation:
∂tν +∇ν · ut = g(ν,x). (23)
In this method, we compute a new grid point X using the scheme below:
X∗ = x−∆tut(x), (24a)
X = x− ∆t
2
(ut(x) + ut(X∗)) . (24b)
We find the scalar field at the next time instant using:
ν∗(x) = ν(X, 0) +∆tg(ν(X, 0), X), (25a)
g∗(x) = g(ν∗(x),x), (25b)
ν(x, ∆t) = ν(X, 0) +
∆t
2
(g(ν(X, 0), X) + g∗(x)) . (25c)
We use cubic interpolation to find field values at non-grid points X and X∗.
Further details on the semi-Lagrangian method can be found in Mang et al.
(2016).
To compute the displacement u, we have to solve Eq. 4c. Since the Lame´ coef-
ficients are variable in the domain, we use the Generalized Minimum Residual
Method (GMRES) to iteratively minimize the residual in the Krylov subspace
of Eq. 4c, up to a user defined tolerance, τ . To increase the convergence rate, we
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precondition the variable elasticity equation by solving it with constant Lame´
coefficients computed by taking their average over the domain. The constant
elasticity coefficient equation can be solved analytically as follows:
Using the identity of ∇· (∇u + ∇uT ) = ∆u + ∇∇· u, we need to solve the
following equation:
Lu = µ ∇u + (λ+ µ)∇∇· u = b. (26)
Given the right hand side b, we need to compute u. Applying the Fourier
transform on both sides, we obtain:
(
µωTωI + (λ+ µ)ωωT
)
û = b̂, (27)
where the hats denote the frequency domain, and ω is the corresponding wave
numbers. We, then, use the Sherman-Morrison formula to compute u:
u = F−1(( 1
µωTω
− 1
(µωTω)2
(λ+ µ)ωωT
1 + λ+µµ
)b̂
)
, (28)
where F−1 is the inverse Fourier transform. We enforce the zero tumor flux
boundary condition and zero displacement boundary condition on the skull
using appropriate smoothed penalized conditions using the penalty method
(see Del Pino and Pironneau (2003); Hogea et al. (2008b) for more details).
For qualitative assessments of mass effect, we compute principal stresses and
maximum shear stress at every time step, using the stress tensor calculated
from Eq. 1a. The principal stresses are visualized by the trace of the stress
tensor and the maximum shear stress is computed from the Mohr’s circle
as:
τmax =
√
(Txx −Tyy)
2
2
+ T2xy, (29)
where T is given in (1b). Further, for sensitivity of mass effect parameters like
forcing factor ζ, we compute the determinant of the deformation gradient (also
known as the Jacobian J) as follows:
J = det(I +∇u), (30)
For the multispecies model, we solve all the equations in a similar fashion as the
single species model. We employ the following operator splitting steps:
– Solve the advection equations ∂tq+∇ · (qut) = 0 for q = (p, i, n, g, w) over
time ∆t using the semi-Lagrangian method with qn as initial condition and
current velocity unt to obtain (p
†, i†, n†, g†, w†).
– Solve the advection equation ∂tf+∇f ·ut = 0 for f over time ∆t using the
semi-Lagrangian method with fn as initial condition and current velocity
unt to obtain f
n+1.
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– Solve the diffusion equations ∂ti−Di = 0 and ∂to−Do = 0 over time ∆t
using the Crank-Nicolson method with i† and on as initial conditions to
obtain i†† and o†.
– Solve the reaction equations ∂tq − Rq = 0 over time ∆t explicitly with
(p†, i††, n†, g†, w†) as initial condition to obtain qn+1. Here, Rq is the re-
action/source operator for Eq. 12a -12e and Eq. 12j - 12k. Update the
reaction, diffusion and elasticity coefficients using the new healthy tissue
and tumor concentration.
– Solve the reaction equation ∂to +Ro = 0 over time ∆t explicitly with o†
as initial condition to obtain on+1.
– Solve the variable linear elasticity equation (Eq. 12i) using Krylov subspace
methods with forcing function and Lame´ coefficients computed from qn+1
to obtain un+1. Update velocity un+1t using backward time differencing.
The numerical parameters used are highlighted in Table 4. The typical num-
ber of Krylov solves for the diffusion equation is around one to three Con-
jugate Gradient iterations. For the preconditioned linear elasticity equations,
the number of GMRES iterations is typically around 50 to 60. Preconditioning
with the constant elasticity operator is quite effective and enables us to reduce
the number of Krylov iterations from over 1000 to about 50. Also note that
the spectral preconditioner is very cheap to apply since it only involves Fast
Fourier transforms.
Table 4: Numerical parameters used in the forward simulations.
Parameter Value
Number of discretization points, Nx =
Ny = Nz
256
Time step, dt 0.01
Tolerance for Krylov subspace solvers,
τ
0.001
Time horizon 1
4 Numerical experiments
We perform a number of simulations to demonstrate qualitatively the behavior
of our scheme, compare the single species with the multispecies model, illus-
trate the mass effect and the effects of screening, and explain how we can use
our scheme to create synthetic MR images. In addition, we conduct a basic
sensitivity analysis for a small number of parameters.
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We perform all simulations using the BrainWeb atlas (Cocosco et al., 1997)
(spatial resolution: 1mm×1mm×1mm), which provides a realistic brain geom-
etry segmented into gray matter, white matter and cerebrospinal fluid. We use
these values as initial conditions for the evolution of material properties and
cerebrospinal fluid. To visualize the results of our simulations, we segment the
brain into material properties and tumor by choosing the label with maximum
cell density at any voxel (Gooya et al., 2011). We overlay tumor concentra-
tions onto these segmentations along with contours of the cerebrospinal fluid at
t = 0 to observe the evolution of tumor cells and tumor-induced deformations
in material properties.
Single species mass effect: We show an exemplary simulation for the single
species model in Fig. 3. As we can see, there is a significant mass effect due to
the growth of tumor on the surrounding tissues. The corresponding point-wise
l2 norm of the displacement fields are also highlighted in Fig. 4. Tissue defor-
mation can be observed around the tumor boundary and it increases as the
tumor grows and spreads. Specifically, we observe large displacements around
the cerebrospinal fluid due to its soft and highly compressible nature.
(a) t = 0 (b) t = 0.15 (c) t = 0.3
(d) t = 0.45 (e) t = 0.6 (f) t = 0.75
Fig. 3: Time evolution of segmentation of the brain and tumor concentration for the
reaction-diffusion model with mass effect. The segmentations are overlayed with contours of
the cerebrospinal fluid at initial time. As one can see, there is significant deformation of the
cerebrospinal fluid and surrounding tissues.
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(a) t = 0 (b) t = 0.15 (c) t = 0.3
(d) t = 0.45 (e) t = 0.6 (f) t = 75
Fig. 4: Time evolution of the point-wise l2 norm of the displacement field, u.
Multispecies mass effect: The results from the multispecies model with mass
effect are shown in Fig. 5. The initial condition for proliferative cells is a
Gaussian mixture and the invasive cells are taken as a small fraction of initial
proliferative cell concentration. To better visualize the evolution of the different
tumor cell types, we count all tumor phenotypes as one for the segmentation
and overlay individual tumor concentrations.
We can see the characteristic multicomponent structure of a glioblastoma along
with significant mass effect on the surrounding tissues in these simulations.
This structure includes the necrotic tumor and tissue cells accumulating in
a central core surrounded by an expanding rim of proliferating tumor cells.
Regarding invasive tumor cells, recent histopathology reports (Eidel et al.,
2017; Gill et al., 2014) show that they infiltrate or diffuse to regions beyond
the enhancing cancer rim. They also indicate that the invasive cell density is
maximum in or around a central necrotic tumor region and becomes smaller
as we move away from this region. We can observe these trends in invasive cell
concentrations in our simulations. A 3D simulation of multispecies mass effect
is shown in Fig. 8. The spatial discretization is equal in all directions.
Stress fields: In order to visualize the stress fields, we show point-wise values
for the principal stresses and maximum shear stress in Fig. 6. We outline how
these are computed from the stress tensor in Eq. 29. The principal stress plot
shows small tensile stresses induced in the tumor core and larger compressive
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Fig. 5: Time evolution of proliferative (column 1 ), infiltrative (column 2 ), necrotic (column
3 ) tumor cell concentrations. The concentrations are overlayed on the whole tumor core
segmentation (proliferative and necrotic tumor). The rows show different time instances of
the simulation: t = 0, 0.2, 0.4, 0.6, 0.8, 1.0.
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stresses around the tumor boundary. The maximum shear stress is induced
around the growing tumor region.
(a) Proliferating tumor
(b) Trace of stress tensor (c) Maximum shear stress
Fig. 6: Normalized stress plots for single species mass effect at t = 1.
Screening effects: We perform simulations for three different values of the
screening coefficient outside the tumor (ηhealthy cells) to observe its effects.
We visualize this in Fig. 7 using contours of cerebrospinal fluid to indicate
the extent of its deformation for the three cases. A large value of ηhealthycells
indicates a highly localized mass effect to regions immediately around the
tumor core. Smaller values result in observable mass effect in regions far away
from the tumor core. However, for tumors close to the ventricles, a long-range
mass effect can lead to their excessive shearing. Hence, a reasonable screening
parameter is helpful for capturing realistic deformations.
(a) ηhealthy cells = 10
6 (b) ηhealthy cells = 10
3 (c) ηhealthy cells = 0
Fig. 7: Effect of screening coefficient, ηhealthy cells on cerebrospinal fluid deformation. The
cerebrospinal fluid contours are overlayed on the initial segmentation for three screening
coefficients.
Simulated MRI images: We use the concentration and segmentation for tumor
cells and healthy cells to simulate MRI images by sampling intensities from
22 S. Subramanian et al.
Fig. 8: Segmented images of 3D simulation showing the evolution of proliferating cells using
the multispecies mass effect model at t = 0 (top row) and t = 1 ( bottom row) for axial slice
123, sagittal slice 97 and coronal slice 161.
real MRI scans taken from the GLISTR dataset (Gooya et al., 2012) and
the BraTS dataset (Menze et al., 2015). We compare simulated T1-Gd MRI
images from the different models in Fig. 9. Unlike the multispecies model, the
single species model provides no information about the enhancing and necrotic
tumor structures. It also does not show edema which can be correlated with
the extent of infiltration by tumor cells. Further, without mass effect, neither
of the models capture realistic deformations of the ventricles and other tissue
types. More exemplar simulated MRI scans are shown in Fig. 10, with varying
initial conditions for the tumor location.
Fig. 9: Simulated T1-Gd MRI images: (left to right) Single species model with and without
mass effect, multispecies model with and without mass effect. The intensities for the tumor
cells in the single species model are sampled from enhancing tumor structures of real MRI
scans.
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Fig. 10: Simulated MRI images (FLAIR, T1, T1-Gd and T2) of tumors with different
initial conditions. The bottom row shows a multi-focal tumor growth simulation. The hyper-
intense regions of the FLAIR images show the extent of edematous fluid and the delineated
enhancing and necrotic tumor structures can be seen from the T1-Gd images. All tumors
produce significant mass effect on the surrounding brain tissue.
4.1 Sensitivity Analysis
We perform a sensitivity analysis to find which parameters in the model are
most sensitive. To determine the effects of the parameters in the multispecies
model, we calculate their respective gradients using finite differences, by vary-
ing one factor at a time:
gι =
‖ι‖ − ‖ι∗‖
‖ι∗‖ , (31)
where ι is the tumor species concentration, ι∗ is an “optimal” species con-
centration (obtained using the parameters from Table 3) and  is a small
perturbation to the parameter in consideration. We assess the sensitivity of
each tumor species to the different parameters by comparing their respective
gradients gι. The results are shown in Table 5. Proliferative cell concentrations
are most sensitive to the oxygen hypoxia threshold (ohypoxia) and the reaction
coefficient (ρ). While the reaction coefficient controls the proliferative rate, the
hypoxia threshold has strong influence on the conditions which lead to phe-
notype switching and necrosis. Other oxygen parameters such as the oxygen
consumption (δp) also affect the concentration, but not as strongly. Invasive
24 S. Subramanian et al.
cell concentrations are most sensitive to the transition rate from proliferative
to invasive cells (α0) and the reaction coefficient since these parameters con-
tribute to the source of invasive cells. Necrotic cells are affected largely by the
death rate (γ), hypoxia threshold and reaction coefficient. None of the tumor
concentrations are sensitive to the transition rate from invasive to proliferative
cells (β0). The solution doesn’t seem to be very sensitive to the diffusion co-
efficient (k) at least for the range of parameters we tested. These results show
a consistent importance of the reaction coefficient and hypoxia threshold for
all tumor species. But, the effect of other parameters is variable amongst the
different species.
Table 5: Sensitivity of the multispecies tumor model on different model parameters evalu-
ated through gradients computed by varying one factor at a time.
Parameter gp gi gn
Reaction coefficient, ρ (see Eq. (10)) 0.377 1.798 0.687
Hypoxia threshold, ohypoxia (see Eq. (14)) -0.532 -0.124 0.369
Deathrate, γ (see Eq. (14)) -0.166 -0.123 0.710
Transition rate from p to i, α0 (see Eq. (17)) -0.029 0.304 0
Oxygen consumption, δp (see Eq. (12g)) -0.240 -0.096 0.247
Oxygen source, δs (see Eq. (12g)) 0.15 0.059 -0.146
Transition rate from i to p, β0 (see Eq. (18)) 0.003 -0.012 0
Diffusion coefficient, k (see Eq. (8)) 0.065 -0.026 -0.042
To assess the sensitivity of the model to mass effect, we perform a grid-search
on two parameters: screening coefficient of healthy cells, ηhealthy cells and forc-
ing function constant, ζ. We report the L2 norm of the Jacobian (determinant
of the deformation gradient, see Eq. 30), J and the maximum distance of a
displacement contour (corresponding to a displacement of 0.1 voxels) from the
initial tumor seed, dmax. This threshold was chosen to visualize the localization
effects of the screening coefficient.
Fig. 11 shows that the deformation Jacobian increases with higher forcing
factors and smaller screening, which is unsurprising. The localization effect of
the screening coefficient is captured in Fig. 12. This results provides us with
information regarding the range of screening coefficients and forcing factors
that would be useful to capture realistic deformations.
4.2 Mesh Convergence
We perform a simple mesh convergence study. We discretize uniformly in all
directions using mesh size h = 2pi/512 as the ground truth/reference and
report the error measure eι for species ι, defined as:
eι =
||ιh − ιref||2
||ιref||2 , (32)
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Fig. 11: Plot of the L2 norm of the re-scaled deformation Jacobian J (see Eq. 30). The
L2 norm of the Jacobian is large for higher forcing factors ζ and lower screening coefficients
ηhealthy cells. High ζ values means large body forces and hence larger Jacobians. With smaller
screening coefficients, the range mass effect is longer resulting in larger Jacobians.
Fig. 12: Plot of displacement metric, dmax. We calculate this for any (ηhealthy cells, ζ) by
finding the displacement contour corresponding to 0.1 voxels and computing the maximum
distance of this contour from the location of the initial tumor seed (which is fixed). Given
an understanding of how large deformations are typically in glioblastoma growth, this figure
shows us how specific ranges of (ηhealthy cells, ζ) can be more useful in obtaining a realistic
tissue displacement.
where ιh is the concentration of species ι at any mesh size h and ιref is the
reference concentration of species ι. We refine both space and time together
to observe our numerical convergence rate. We report our results in Table 6.
We can observe an approximate first order of convergence for our numerical
schemes, as expected.
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Table 6: L2 convergence error rates eι for different model species. The table shows an
approximate linear convergence rate as expected for our numerical methods.
Mesh size, h ep ei en eg ew
2pi/64 0.5677 0.1904 0.1677 0.2984 0.2421
2pi/128 0.3437 0.1483 0.0986 0.1379 0.1171
2pi/256 0.1510 0.0645 0.0382 0.0291 0.0292
5 Conclusions and Future Work
We presented a model that captures the phenomenological features of glioblas-
tomas seen on MRI scans. These features include a multicomponent structure
of a glioblastoma and tumor-induced mass effect on surrounding brain tissue.
We coupled a multispecies “go-or-grow” tumor model with linear elasticity
equations and presented results to illustrate the capabilities of our model in
capturing different tumor characteristics using novel numerical schemes. We
are currently working on extending the sensitivity analysis and understand-
ing the important parameters of the model by formulating an inverse problem
and directly inverting for parameters from images using adjoint-based gradient
methods.
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